Erratum: Expression of concern “Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes” [Pharmacol. Res. 57/2 (2008) 159–169, (S1043661808000157), (10.1016/j.phrs.2008.01.005)];Simvastatin enhances VEGF production and ameliorates impaired wound healing in experimental diabetes

Pharmacological Research

Volumn 57, Issue 2, 2008, Pages 159-169

  Bitto, Alessandra ^a   Minutoli, Letteria ^a   Altavilla, Domenica ^a   Polito, Francesca ^a   Fiumara, Tiziana ^a   Marini, Herbert ^a   Galeano, Mariarosaria ^a   Calò, Margherita ^a   Cascio, Patrizia Lo ^a   Bonaiuto, Michele ^a   Migliorato, Alba ^a   Caputi, Achille P ^a   Squadrito, Francesco ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Diabetes; PECAM 1; Simvastatin; VEGF; Wound healing

Indexed keywords

BETA ACTIN; CD31 ANTIGEN; MESSENGER RNA; NITRIC OXIDE; SIMVASTATIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACK; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; EXPERIMENTAL DIABETES MELLITUS; FEMALE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INJURY; STRENGTH; WOUND HEALING IMPAIRMENT;

EID: 40149098316     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2023.106897     Document Type: Erratum

References (33)

1. Inoguchi T., and Nawata H. NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome. Curr Drug Targets 6 (2005) 495-501
2. Wassmann S., Wassmann K., and Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension 44 (2004) 381-386
3. Zykova S.N., Jenssen T.G., Berdal M., Olsen R., Myklebust R., and Seljelid R. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 49 (2000) 1451-1458
4. Altavilla D., Saitta A., Cucinotta D., Galeano M., Deodato B., Colonna M., et al. Inhibition of lipid peroxidation restores impaired vascular endothelial growth factor expression and stimulates wound healing and angiogenesis in the genetically diabetic mouse. Diabetes 50 (2001) 667-674
5. Diegelmann R.F., and Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 9 (2004) 283-289
6. Galeano M., Deodato B., Altavilla D., Cucinotta D., Arsic N., Marini H., et al. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46 (2003) 546-555
7. Deodato B., Arsic N., Zentilin L., Galeano M., Santoro D., Torre V., et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 9 (2002) 777-785
8. Yla-Herttuala S. An update on angiogenic gene therapy: vascular endothelial growth factor and other directions. Curr Opin Mol Ther 8 (2006) 295-300 [Review]
9. Holash J., Maisonpierre P.C., Compton D., Boland P., Alexander C.R., Zagzag D., et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284 (1999) 1994-1998
10. Vijan S., and Hayward R.A. American College of Physicians. Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med 140 (2004) 650-658 [Review]
11. Kureishi Y., Luo Z., Shiojima I., Bialik A., Fulton D., Lefer D.J., et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 6 (2000) 1004-1010
12. Park H.J., Kong D., Iruela-Arispe L., Begley U., Tang D., and Galper J.B. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ Res 91 (2002) 143-150
13. Matsuno H., Takei M., Hayashi H., Nakajima K., Ishisaki A., and Kozawa O. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J Cardiovasc Pharmacol 43 (2004) 333-340
14. Frick M., Dulak J., Cisowski J., Jozkowicz A., Zwick R., Alber H., et al. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 170 (2003) 229-236
15. Pierce G.F., Mustoe T.A., Senior R.M., Reed J., Griffin G.L., Thomason A., et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-cis gene homodimeric proteins. J Exp Med 167 (1988) 974-987
16. Prueksaritanont T., Ma B., Fang X., Subramanian R., Yu J., and Lin J.H. beta-Oxidation of simvastatin in mouse liver preparations. Drug Metab Dispos 29 (2001) 1251-1255
17. Wassmann S., and Nickenig G. Interrelationship of free oxygen radicals and endothelial dysfunction-modulation by statins. Endothelium 10 (2003) 23-33
18. Jones S.P., Trocha S.D., and Lefer D.J. Pretreatment with simvastatin attenuates myocardial dysfunction after ischemia and chronic reperfusion. Arterioscler Thromb Vasc Biol 21 (2001) 2059-2064
19. Chen J., Zhang Z.G., Li Y., Wang Y., Wang L., Jiang H., et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53 (2003) 743-751
20. Sata M., Nishimatsu H., Osuga J., Tanaka K., Ishizaka N., Ishibashi S., et al. Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis. Hypertension 43 (2004) 1214-1220
21. Ungvari Z., Pacher P., and Csiszar A. Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?. Med Hypotheses 58 (2002) 85-86
22. Siddiqui A.J., Gustafsson T., Fischer H., Widegren U., Hao X., Mansson-Broberg A., et al. Simvastatin enhances myocardial angiogenesis induced by vascular endothelial growth factor gene transfer. J Mol Cell Cardiol 37 (2004) 1235-1244
23. Roy H., Bhardwaj S., and Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 580 (2006) 2879-2887 [Review]
24. Eming S.A., and Krieg T. Molecular mechanisms of VEGF-A action during tissue repair. J Investig Dermatol Symp Proc 11 (2006) 79-86 [Review]
25. Kimura H., and Esumi H. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 50 (2003) 49-59 [Review]
26. Perry B.N., and Arbiser J.L. The duality of angiogenesis: implications for therapy of human disease. J Invest Dermatol 126 (2006) 2160-2166 [Review]
27. Kimura H., Weisz A., Kurashima Y., Hashimoto K., Ogura T., D'Acquisto F., et al. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95 (2000) 189-197
28. Park H.J., and Galper J.B. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc Natl Acad Sci USA 96 (1999) 11525-11530
29. Roberts A.B., and Sporn M.B. Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). Growth Factors 8 (1993) 1-9
30. Zambruno G., Marchisio P.C., Marconi A., Vaschieri C., Melchiori A., Giannetti A., et al. Transforming growth factor beta-1 modulates beta-1 and beta-5 integrin receptors and induces the de novo expression of the alpha v beta-6 heterodimer in normal human keratinocytes: implications for wound healing. J Cell Biol 129 (1995) 853-865
31. Galiano R.D., Tepper O.M., Pelo C.R., Bhatt K.A., Callaghan M., Bastidas N., et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164 (2004) 1935-1947
32. Park K.W., Hwang K.K., Cho H.J., Hur J., Yang H.M., Yoon C.H., et al. Simvastatin enhances endothelial differentiation of peripheral blood moonuclear cells in hypercholesterolemic patients and induces pro-angiogenic cytokine IL-8 secretion from monocytes. Clin Chim Acta 388 (2007 2008) 156-166
33. Frick M., Dulak J., Cisowski J., Józkowicz A., Zwick R., Alber H., et al. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. Atherosclerosis 170 (2003) 229-236